Introduction
A large number of extracellular proteins with diverse funCtions, including those associated with blood coagulation and fibrinolysis, activation of complement, cell adhesion, and developmental determination of embryonic cell fates, contain epidermal growth factor (EGF)-like domains (for reviews see Stenflo, 1991; Campbell and Bork, 1993) . This cysteine-rich domain, first described in EGF itself (Savage et al., 1972) , contains -40-50 amino acid residues including six conserved cysteine residues that form three disulphide bonds. The domain may exist as a single copy or as multiple copies within proteins and in association with §Present address: Rockefeller
Research Laboratory, Sloan-Kettering institute, New York, New York 10021.
other different protein modules (Campbell and Bork, 1993) . Because of its widespread distribution among extracellular proteins, there has been considerable interest in the biological role of the EGF-like domain, which is presumed to be involved in mediating protein-protein interactions (Campbell and Bork, 1993) .
A subset of EGF-like domains contain five amino acids that constitute a Ca--binding consensus sequence: Asp/ Asn, Asp/Asn, GlnlGlu, Asp*/Asn*, Tyr/Phe, in which the asterisk may be a fi-hydroxylated residue (Rees et al., 1988; Handford et al., 1991) . Ca2+ binding to this type of domain was first demonstrated in the vitamin K-dependent plasma proteins: factors IX and X, protein C, and protein S (Ohlin et al., 1988; Huang et al., 1989; Persson et al., 1989; Handford et al., 1990; Dahlback et al., 1990 ). Subsequently, Ca% was shown to bind to EGF-like domains from the connective tissue protein fibrillin-1 (Glanville et al., 1994; Handford et al., 1995) . The importance of each of the consensus residues for ligand binding was established by extensive mutagenic studies on the Ca2+-binding EGF-like domain from human clotting factor IX (Handford et al., 1991; Mayhew et al., 1992; Hughes et al., 1993) .
The functional importance of Ca*+ binding was demonstrated by the identification of mutations causing amino acid changes in consensu8 residues, first in hemophilia B patients defective in coagulation factor IX (Winship and Dragon, 1991) , and more recently in Marfan syndrome patients defective in fibrillin-1 (Dietz et al., 1993; Hewett et al., 1993; Kainulainen et al., 1994) . Moreover, the transmembrane proteins Notch and Delta, product8 of the Drosophila neurogenic loci, have been shown to interact in vitro at the cell surface via their extracellular domains in a Ca2+-dependent manner (Fehon et al., 1990) . Each of these proteins contains multiple extracellular EGF repeats. Notch has 38 EGF-like domains and Delta has 9, of which at least 8 and 1, respectively, contain Ca2+-binding sequences. Notch and Delta appear to cooperate in mediating cell-ceil communication required for proper differentiation of neural lineage8 and are examples of an ever increasing family of proteins containing domains homologous to EGF that play an important role in the control of different developmental processes. Homologs of Notch have been described in Caenorhabditis elegans (LIN-12; Yochem et al., 1988; Wilkinson et al., 1994) , in humans (TAN-l ; Ellisen et al., 1991) , and in Xenopus (Xotch; Coffman et al., 1990) . Another member of this family, crumbs, contains 30 EGF-like domains, of which at least seven are of the Ca2+-binding type, and plays a key role in the organization of epithelia in Drosophila (Tepass et al., 1990) .
Extensive structural studies have been carried out on this type of EGF-like domain, principally 'H nuclear magnetic resonance (IH-NMR) investigations of the structure of the domain from clotting factors IX and X ( Baron et al., 1992; Selander et al., 1990; Selander-Sunnerhagen et al., 1992) . These showed that the overall fold of this domain R -= Z&/l,,, -(lr,)l/E,,C (Ih) in which h are unique reflection indices, I,,h are intensities of symmetry redundant reflections, and lh is the mean intensity. MFID is the mean fractional isomorphous difference. FM is the overall figure of merit: the cosine of the mean phase error of the phases. <F>/<E> is the phasing power: the rms value of Fn divided by the rms lack of closure error. RI, = Zhl IF& -IF,/, J/&lF&, where the sum is over the unique reflections, h.
was similar to that observed in EGF itself, the main structural feature being a two-stranded f3 sheet. Although these studies provided medium resolution information on protein conformation and indirect information on the ligands involved in binding CaH, they failed to identify structural features of this domain complexed with CaH that might explain its widespread distribution among extracellular proteins.
We have now determined a high resolution X-ray crystallographic structure of the Ca2+-binding EGF-like domain from factor IX. This structure provides experimental evidence for a novel use of Ca2+ in stabilizing protein-protein interactions that is consistent with a general biological role for this domain.
Results and Discussion
The Structure:
Flexibility and Strain We have determined the crystal structure of residues 46-64 of human clotting factor IX, which comprise the first EGF-like domain of the molecule, by the method of isomorphous replacement. Although the crystals are well ordered and diffract X-rays to high resolution (1.5 A), the structure determination was hindered by the difficulty of obtaining useful heavy-atom derivatives and relied on the accurate measurement of anomalous differences by the use of synchrotron radiation, as described in the Experimental Procedures. The present model has a crystallographic R factor of 15.7% for all measurements between 30 and 1.5 Figure 1 . Stereoview of a Segment of the Electron Density Map (2F, -Fc) Calculated at 1.5 i Resolution and Contoured at 1.60
The strand of polypeptide running from left to right across the top of the picture comprises residues 69-74, with the sequence YECWCP. The rms deviation in Ca positions is 0.4 A. The most significant differences occur between Glu-52 and Ser-53. where the deviations are 1.2 and 0.9 A, respectively. (C)Comparison of the three-dimensional structures of EGF-like domains of factors IX and X, shown in stereo. (i) EGF-like domain of factor IX (molecules I and II, red and yellow, respectively; this study); (ii) Ca%-free NMR structure for the factor IX module, in cyan (Baron et al., 1992) ; (iii) Ca=-free NMR structure for the corresponding module from factor X, in green (Selander et al., 1990) ; (iv) a C-terminal EGF-like domain from the crystallographic structure of factor X, in pink (Padmanabhan et al., 1993) . Note that while the two molecules in our crys tals agree with an rms deviation of CR atoms of 0.4 A, the corresponding values for our structures compared with th8 others are between 1.4 and 1.5 A.
a and excellent stereochemistry typified by a root mean chains. The overall structure of the domain is elongated square (rms) deviation from ideal bond lengths of 0.010 ( Figure 2A) , with dimensions 65 A x 15 A x 15 A. There a (Table l) , and the electron density map is of high quality is little extended secondary structure, only a 6 hairpin (resi- (Figure 1 ). The unusual precision of this study allowed dues 61-65 and 66-76). However, there are six 6 turns, us to detect and model multiple conformations in 12 side two of them locked together. Of these turns, three are -54,65-66, and 74-76) two are type I (residues 49-52 and 79-62), and one a type I' (57-60). Since there are two independent copies of the polypeptide (I and II) in each asymmetric unit of the crystal, we can assess the flexibility of the structure. The two molecules are extremely similar ( Figure 28 ; rms deviation in Ca positions 0.4 A, in which we estimate the error in the coordinates to bs somewhat less than 0.2 A for the majority of the structure), indicating that the domain has a single well-defined structure in the presence of Ca2+. However, the individual B factors (which indicate the degree of flexibility within the crystal) for the two copies do not, overall, correlate well (correlation coefficient = 0.035; Acharya et al., 1991) . Inspection of the variation in 6 factor as a function of position in the molecule (Figure 3) shows that the local variations in flexibility are in fact rather similar between the two molecules. However, the crystal contacts "pin-down" opposite ends of the two molecules so that there is an overall, and opposite, trend in the B factors within each molecule. This effect is not seen in larger globular proteins and reflects the elongated, slightly flexible nature of this relatively small domain.
The unusual nature of the structure of the domain is reflected in the amino acid composition, which is skewed compared with most globular proteins, with only eight hydrophobic residues (the expected value would be 16 amino acids for a polypeptide of this length; McCaldon and Argo% 1966). Thus, apart from the disulphide bonds that arevirtually solvent inaccessible and one of the Caz+-binding consensus residues (Tyr-69) that is largely buried, the molecute has lit&r in the way of a hydrophobic core ( Figure  3 ). Although no residues lie in disallowed regions of the Ramachandran plot, almost one quarter lie in less favored regions (Fylure 4A). (This is more than expected for a weff-folded gtobular protein [Laskowski et al., 19931 ; however, given the high resolution of the X-ray analysis, we are confident that it is not artifactual.) We believe that this may reffect the unusual structure of the domain, in particular, the lack of both regular secondary structure and a stabilizing hydrophobic core in this disulphide-rich domain. Evidence supporting the role of the disulphide bonds in maintaining a strained molecular conformation green, and residues whose backbone torsion angles are less favOred (as defined by PROCHECK; Laskowski et al., 1993) are coiored red. The disuiphide bonds are shown in yellow and the Ca% in purple. is presented in Figure 48 , where the residues with less favored backbone torsion angles are colored red. Note that the pattern of strain is very similar between the two molecules and lies entirely in loops between cysteine residues.
Calcium Ligation Proton microprobe studies (Rao et al., 1995; E. Garman et al., unpublished data) indicated the Ca*+:protein stoichiometry to be 1.7 ( f 0.2):1. In agreement with this, the refined crystal structure contains three Ca% associated with a pair of domains, I and II (see Figure 2A) . Two of these Ca& sites are well defined ( Figure 5 ) and tightly formed, as judged by the crystallographic B factors that indicate that the Ca-s (B = 12 AT are as rigidly defined as the surrounding protein (B = 14 A2 for the Ca atoms of the surrounding residues). The third is less rigidly bound (B = 23 A'), with imperfect ligation.
Of the 'H-NW structures that have been reported for the Ca*-binding EGF-like domains from factor IX and the homologous protein factor X ( Baron et al., 1992; Selander et al., 1990; Selander-Sunnerhagen et al., 1992) only one was determined in the presence of Ca*+ (Selander- Sunnerhagen et al., 1992) and even in that study, the technique was "blind" to the position of the Ca*+, which could only be inferred from the structure of the protein. The structures determined by NMR are broadly similar to, although less precise than, our crystal structure. Thus, the rms deviation in Ca atoms between molecule I in our crystals and its Caa-free structure determined by NMR is 1.4A (Baron et al., 1992) while the corresponding value for the homologous domain from factor X is 1.5 A (Selander et al., 1999).
However, the Ca*+-free structures diverge from our Ca*+-bound structures in some regions, most significantly the N-terminal portion, which contributes the majority of the Ca% ligands (see below). Thus, if we consider only residues up to and including 49, the corresponding rms deviations rise to 2.8 and 2.9 A, respectively, suggesting that Cd+ introduces a local conformational change in the N-terminal region (see Figure 2C) .
In spite of the limitations of the NMR experiments, the ligands suggested in one study (Selander-Sunnerhagen etal., 1992) areconfirmed byourcrystalstructure, in which they occur at the tight Ca'+-binding site, although we see, in total, seven liganding oxygen atoms compared with the five suggested from the NMR data. This major Ca*+-binding site is located between a two-stranded 8 sheet and the N-terminal loop in each of the two molecules. In both molecules, the details of the Ca-ligation are essentially identical: the seven ligands form a pentagonal bipyramid ( Figure 5 ) with an average Ca%-0 distance of 2.3 A. This coordination geometry is typical of that observed in many Ca2+-regulated proteins (for review see Strynadka and James, 1989) .
If we consider the Ca*+ most closely associated with molecule I, six of the ligands come from that molecule, four are supplied by carboxylatelcarboxyamide side chains (atoms ODl and OD2 of Asp-84, OEl of Gln-50, and ODl of Asp-47), and two are supplied by main-chain carbonyl oxygen atoms Gla domain of prothrombin were used to model residues l-45 of the factor IX Gla domain (Gla domain shown in yellow, whereas the EGNike domain is color ramped, blue to green, between N and C domain termini). The Gla-00 residue is shown. The polypeptide backbone has not be?r~ altered from that observed in the respective crystal structures, and yet residues Tyr-45 (top left) and Val-46 (top right) approach to within -3 A. The hydrophobic restdues immediately preceding residue 45 and the CaZf site immediately following residue 46 (Ca-shown in purple) confer stringent structural restrictions on this modeling. There are extensive stabilizing interactions between the two domains as modeled. Handford et al., 1991; Mayhew et al., 1992) interact directly with the Ca=. One of the others, Tyr-69, has an important structural role (as noted above, it has strong hydrophobic interactions, in particular with Pro-55), in agreement with earlier mutagenic studies (Hughes et al., 1993) which showed that a TyrVal substitution at residue 69 caused a reduction in the yield of correctly disulphide-bonded material when the isolated EGF domain was refolded in vitro. These studies also demonstrated that Tyr-69 was essential for clotting activity of recombinant factor IX. The final consensus residue, Asp-49, which had been proposed to be a direct ligand (Handford et al., 1991) , in fact plays an indirect role: the carboxylate side chain of this residue forms a crucial hydrogen bond with the main-chain amide nitrogen of Cys-51, forming an ASX turn, a structure previously observed in another high affinity Ca2+-binding site (Stuart et al., 1979; Rees et al., 1993) . Mutagenic studies support such a structural role for this residue; an asparagine substitution, which can still form the crucial hydrogen bond and, hence, maintain the conformation of the Ca%-binding loop, has only a minor effect on Ca* binding (Mayhew et al., 1992) .
The minor Ca*+-binding site is located on the surface of the N-terminal loop of molecule I (see Figure 2A) . The Ca% occupying this site is coordinated by eight ligands, comprising six water molecules, the main-chain carbonyl oxygen, and the side-chain hydroxyl of Ser-53. It is uncertain whether this site is of physiological significance, since in human factor IX Ser-53 is posttranslationally modified with carbohydrate (Hase et al., 1988; Nishimura et al., 1989) . Furthermore, this Ca2+ site is not occupied in molecule II.
Bole of Repeated Caz+-Binding Domains The most likely explanation for the recurrence of the multiple Ca2+-binding EGF-like domains within proteins is that they are involved in Ca2+-mediated protein-protein interactions, either with other such domains or with different structural motifs. While our crystal structure is only of a single domain, there is now considerable evidence that the essential features of such protein-protein interactions may, on occasion, be recapitulated in the crystalline state owing to the adhesive interactions that forge the crystal lattice. An early example of this was the homophilic interactions between molecules of the cell adhesion immunoglobulin superfamily molecule CD2 (Jones et al., 1992) $;cture of a Ca2+-Binding EGF-like Domain that reveal the essential features of the general mode of adhesive interactions between immunoglobulin domains (demonstrated by further structural studies [Bodian et al., 1994) and mutagenesis results [van der Merwe et al., 19953) . Very recently, the structure of an integrin I domain (Lee et al., 1995) provides an example even more closely analogous to the present work, in which a metal ion is shared between two molecules, providing a compelling illustration of the long-standing hypothesis for the role of metal in mediating integrin-ligand interactions. Our crystals appear to be particularly illuminating in this respect, allowing us to make a number of predictions regarding the biological function of this domain in a variety of proteins. Perhaps the clearest examples of this are for proteins that contain many Ca*-binding EGF-like repeats in tandem, often with extremely short linkers between them. Fibrillin-1 , a major structural component of a subset of connective tissue microfibrils, is such a protein. It contains 43 of these domains arranged in 9 segments, one of which includes 12 contiguous EGF-like domains (Pereira et al., 1993; Corson et al., 1993) . Evidence from patient studies demonstrates that defective CaB binding to a single EGF-like domain within fibrillin-1 can lead to the clinical condition known as the Mar-fan syndrome (Dietz et al., 1993; Hewett et al., 1993) . The elongated ultrastructural appearance of the molecule (Sakai et al., 1991) suggests that there is a repeated mode of interaction between adjacent EGF-like domains. Given these known constraints, it is of interest that the crystals we have analyzed are built from tightly wound helices of domains, with a Ca*+ stabilizing and defining the geometry of the domaindomain interface ( Figure 6A ). These experimentally observed Ca2+-stabilized 63 helices, with a pitch of 33 A and a diameter of 40 A, provide us with a model for the interaction of these domains in fibrillin that is compatible with our current knowledge of the microfibril structure (Sakai et al., 1991) and that also would explain how the loss of a single Ca2+-binding site could destabilize the microfibril, leading to the Marfan syndrome. Although the stacks observed in the crystals clearly represent a stable assembly for such domains, since they are not linked in a single covalent chain, there is no a priori reason to expect the adjacent units to present their chain termini in proximity, as would be required for molecules such as fibrillin-1 in which there are often very short linkers between adjacent domains. In fact, the termini are a mere 4 A apart ( Figure 6A ). The de facto satisfaction of such a stringent unseen constraint adds considerable weight to the argument that the structures we observe are avalid model for proteins with multiple Ca2+-binding EGF-like repeats.
The higher order association of such helices, either parallel or antiparallel, would allow extensive protein-protein interactions between two such molecules (once again the packing of the helices in the crystal provides a very plausible starting model for such associations; Figure 6A ). Homotypic interactions of this type would provide a mechanism for the association of fibrillin monomers within a microfibril (Sakai et al., 1991) . Heterotypic interactions of this type could be responsible for the Ca2'dependent association demonstrated by Notch and Delta and would provide an explanation for the ability of Notch to act as a multifunctional receptor for other developmentally important proteins with EGF-like domains such as Serrate (Rebay et al., 1991) . Deletion analyses have localized the region of Notch that binds Delta to EGF-like repeats 11 and 12, both of which are predicted to be Ca2+-binding domains (Rebay et al., 1991) . Significantly, it is a pair of domains that acts as the minimum functional unit, and neither EGF-like repeat 11 nor 12 alone supports binding. This result is consistent with our structural data that show that protein-protein interactions between EGF-like domains in the crystal. are Caz+ dependent, and therefore, domains are unlikely to function independently of one another. We predict that mutations that change Ca%-binding residues in either domains 11 or 12 of Notch would abolish the Notch-Delta interaction, since this would lead to a destabilization of the proposed helical structure formed from sequential Caw-binding EGF-like domains. Although our model forthe heterotypic associationof Ca2+-stabilized helices provides an explanation for the interaction of Notch with Delta and other related proteins, the identification of structural features that determine the specificity of such interactions remains a challenging area of research.
Our model for the association of EGF-like domains would also explain some of the properties of protein S, an important regulator of coagulation, which has four consecutive EGF-like domains of the Ca%-binding type. It is interesting to note that the Car+ binding affinity exhibited by this protein is at least an order of magnitude greater than that in factors IX, X, and the homologous protein C (Dahlback et al., 1990) . Since the linking region between the four domains is very short, our crystal packing provides a natural model for protein S in which the donation of a Ca* ligand from an adjacent EGF-like domain stabilizes the domain interface, facilitating Ca% binding to the next domain. Inspection of the known amino acid sequences of EGF-like domains from each of the above mentioned proteins (a synoptic compilation of sequence aligments is presented in Figure 3) shows that a residue equivalent to Asn-66 is present that could donate an oxygen ligand to complete the Ca2+ coordination in the adjacent domain, although in some cases, variations in loop length render the assignment ambiguous.
Role in Clr and Cls Like factors IX and X, the homologous complement serine proteases Cl r and Cl s each contain a single Ca2+-binding EGF-like domain (for review see Arlaud et al., 1969; Day et al., 1993) . These proteins mediate heterologous and homologous Ca*dependent interactions involved, respectively, in the formationof theCls-Clr-Cl r-Cls tetramer(partof the first component Cl of theclassical pathway of complement) and the Cls-Cls homodimer. Studies on the Ca"-binding properties of proteolytic fragments derived from these proteins, in particular those derived from Cls, support an important role for the single Ca2+-binding EGFdomain in stabilizing protein-protein interactions. a2, a proteolytic fragment derived from plasmin treatment of Cls, which contained the Ca2+-binding EGF-like domain, failed to exhibit native binding of Ca* and to bind to Cl r A Y in the appropriate column indicates that the mutation was studied in patients (from Giannelli et al., 1994 with a few omissions), or in isolated domains (Handford et al., 1991; Mayhew et al., 1992; Hughes et al., 1993) or in protein-engineered intact factor IX (Rees et al., 1966; Hughes et al., 1993) . A question mark indicates an unknown effect of the mutation on structure.
in the presence of Ca*+ and was unable to dimerize (Thielens et al., 1990a) . However, a fragment (Cl sa) containing both the EGF-like domain and the adjacent N-terminal domain of Cls bound Ca2+ with almost native affinity and formed homodimers and Ca=dependent tetramers with native Cl r (Thielens et al., 199Ob) . These data are consistent with the N-terminal domain providing a ligand to complete the coordination sphere of Ca-bound to the EGFlike domain. However, it should be noted that structural features in addition to Ca*+ binding to the EGF-like domain are likely to be involved in mediating the dimerization of Cls, since a homologous Clr fragment (Clra) does not form homodimers (Thielens et al., 1990b) .
Role in Factors IX and X Factor IX does not possess tandem Ca*-binding EGF-like domains. However, Ca* binding to the isolated EGF-like domains from factors IX and X is 29 to 40-fold reduced compared with the high affinity binding exhibited by the native protein (Handford et al., 1991; Persson et al., 1989) suggesting a role for Ca*+ in modulating protein-protein interactions. In both factors IX and X, a ycarboxyglutamyl (Gla) domain is N-terminal to the EGF-like domain, linked to it by a short hydrophobic region (Stenflo, 1991) . In factor X, high affinity Ca* binding is restored if a fragment containing residues 29-45 of the Gla-hydrophobic domain is attached to the isolated Ca*+-binding EGF-like domain (Valcarce et al., 1993) . As observed above in our crystals, the seventh Ca2+ ligand is also donated N-terminal with respect to the Ca2+-binding site in the adjacent EGF-like domain, suggesting that a Ca* ligand substituting for Asn-58 may be provided by a residue in this sequence. Fortunately, coordinates for the homologous Gla domain of prothrombin fragment 1 are available (Soriano-Garcia et al., 1992) and given the structural overlap between this molecular fragment and ours (the prothrombin fragment 1 structure extends beyond the Gladomain, providing linker residues; see legend to Figure 8B ), there are avery limited range of possible orientations between these domains that will present a seventh ligand to the Ca% bound to the EGF-like domain. Modeling, treating the observed structures as rigid bodies, is therefore relatively straightforward and unambiguous ( Figure 68 ) and suggests that one or other of the carboxylate groups of Gla-40 is the most likely candidate. Recent 'H-NMR structural determination of the homologous Gla-EGF domain protein fragment from bovine factor X, performed in the presence of limiting [Caz+] such that only the high affinity site within the EGF domain is saturated, shows that the Gla domain folds over the EGF domain in the region of the Ca2+-binding site and thus lends experimental support to our modeling studies (Selander-Sunnerhagen, 1994) . Currently, no Glad0 mutants of factor IX have been identified in hemophilia B patients (Giannelli et al., 1994) , although our prediction of Ca2+ binding to residue 40 could be tested experimentally by comparing Ca2+ binding of wild-type and mutant factor IX protein fragments encompassing residues 29-84. Mutations at position 40 should significantly reduce high affinity Ca% binding. On the basis of the crystallographic structure, ie can predict accurately the effect not only of naturally occurring mutations, as observed in hemophilia B patients with defective factor IX and in Marfan syndrome patients defective in the connective tissue protein fibrillin, but also synthetic mutations. Predictions for the Ca2+-binding EGF-like domain of factor IX are detailed in Table 2 . While most mutations are explicable by reference to the local structure of the domain, a few are not (e.g., substitutions at . It is possible that these produce an effect by interfering with normal protein-protein contacts either within factor IX or with other components of the clotting cascade, such as factors Villa or X.
Conclusions
In summary, the crystal structure of a Ca2+-binding EGFlike domain from factor IX has defined the seven ligands in a novel type of extracellular Ca2+-binding site and has fully explained the structural significance of the Ca2+-binding consensus sequence associated with this domain. The helical arrangement of the domains in the crystal has allowed us to propose a general mechanism, consistent with known functional data, by which Ca* bound to EGFlike domains can stabilize protein structure and direct protein-protein interactions. This novel mechanism accounts for the presence and biological importance of this type of domain in functionally unrelated extracellular proteins.
Exprlmental Procedures
Clystalllxatlon and Data Collectlon
The EGF-likedomain, residues4664of human factor IX, was purified and crystallized as described elsewhere (Mayhew et al., 1992; Rao et al., 1995) . Crystals (largest size, 1.0 x 0.5 x 0.3 mm3 belong to the tetragonal spa? group P4&!,2, with unit cell dimensions a = b = 40.3 A, c = 96.2 A. There are two molecules in the asymmetric unit. The crystals diffract beyond 1.5 A and are relatively stable in the X-ray beam.
Structure
Determlnatlon Heavy-Atom Derivatives The crystals were stabilized in 0.1 M Tris-HCI buffer with 55% PEG 400 (pH 7.3) incubated at room temperature for 4-72 hr with different heavy-atom reagents.
Data Collection
Data sets were collected in-house on a Seimens multiwire area detector or Marresearch imaging plate detector. Synchrotron data were collected at the SRS Daresbury stations 9.5 and 9.6 and at CHESS station Fl. Initial data processing used programs MOSFILM (A. Leslie, personal communication), XDS (Kabsch, 1966) and DENZO(Ctwinowski, 1993) and further processing used in-house programs (Stuart et al., 1979) . A set of native data was created from a number of data sets to Bragg spacing of 2.0 A for initiql phasing and refinement.
Further native data was coll~ed to 1.5 A at station 9.6 at Daresbury and merged with the 2.0 A data for final refinement. Over 90 derivatives were screened; the w(CN), derivative was substituted at a single site, lying almost exactly on a crystallographic 2-fold axis (0.11, 0.09, 0.00). To improve the anomalous scattering data for this derivative, data were collected (on a Marresearch imaging plate detector) using radiation of wavelength 0.692 A at station 9.5 at Daresbury. An additional minor derivative was obtained by soaking a crystal in a cocktail of nine different heavy-atom reagents; a single heavy atom, of unknown chemistry, became loosely associated with the protein (also very close to a special position; coordinates 0.21, 0.51, 0.05). Difference Patterson maps were interpreted using GROPAT (Jones et al., 1991) . Heavy-atom parameter refinement and phase determination for the two derivatives were performed using MLPHARE (in the CCP4 program suite; Collaborative Computational Project, 1994) and electron information from the K#t(CN)r derivative played a crucial role in the phasing. The quality of the electron density was sufficient to determine reliable residue positions throughout, and an initial model was built based on the NMR structure (Baron et al., 1992) using the program FRODC (Jones, 1965) .
Refinement

Initial refinement
was. by simulated annealing with XPLOR 3.1 (Briinger, 1992) at 2.0 A with tightly restrained chemistry and no local symmetry restraints after the second cycle of refinement. Further refinement to 1.5 A was carried out by positional and temperature factor refinement using XPLOR, using the stereochemical parameters of Engh and Huber (1991) . During the course of the refinement, water sites were gradually added and the stereochemical restraints modified, so that, eventually, electrostatic and van der Waals terms were omitted from the target function. For 12 residues (molecule I, Lys-63, Asp-65, Glu-70, Glu-76; molecule II, Glu-52, Lys-63, Asp-65, Glu-70, Trp-72, Phe-75, Glu-76, Glu-63). alternative sidechain conformations were built and several partially occupied water sites were added. In total, the model includes 206 water moleules (including 116 that have been assigned an occupancy of 0.5). The final crystallographic R factor of 15.7% is for all measurements between 36 and 1.5 A Bragg spacings with a bulk solvent correction (as implemented within XPLOR; Briinger, 1992). The R factor for the 1.6-l 5 A shell of data is 28.2%.
Flgurw
Figures 1 and 6A were produced using FRODO (Jones, 1965) . Figures  2, 46 , 5, and 68 were produced using a version of MOLSCRIPT (Kraulis, 1991) modified by R. Esnouf and rendered with RASTERID (Merritt and Murphy, 1994) . In Figure 3 , sequence alignments were produced using ALSCRIPT (Barton, 1993) . and solvent accessibilities were calculated using the program DSSP (Kabsch and Sander, 1963 
